Purchase Order 75N92025P00152
Award Date
4/4/25
Potential Completion Date
10/6/25
Potential Value
$10K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Repeat Diagnostics Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,500.00, was granted by the National Heart, Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a specialized laboratory services provider based in Ottawa, Canada. The contract is for the provision of telomere length measurement services using flow fluorescence in situ hybridization (flow-FISH) assays to support NHLBI's "YOUNG LAB" research initiative. The goal of this research...
The National Institutes of Health National Heart, Lung and Blood Institute awarded a firm fixed price purchase order valued at $21,000 to Repeat Diagnostics Inc. of Ottawa, Canada. Under this contract, Repeat Diagnostics will provide telomere length measurement services using flow fluorescence in situ hybridization (flow-FISH) assay for samples from the Young Lab Members at NIH NHLBI. The work will involve testing patient samples from the lab's clinic to repeat their telomere length...
This is a $65,800 firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Repeat Diagnostics Inc., a for-profit limited liability company based in Ottawa, Canada. The contract is for laboratory services to perform telomere length measurement using a 6-panel flow fluorescence in situ hybridization (flow-FISH) assay. This contract supports NCI's research into the correlation between telomere length and...
The National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), awarded a $16,750.00 firm fixed-price purchase order contract to Repeat Diagnostics Inc., a specialized laboratory services provider based in Ottawa, Canada. The contract is for the provision of 2-panel assays to measure telomere length using flow fluorescence in situ hybridization (flow-FISH) technology. These services support NHLBI's biomedical research efforts, enabling clinicians to...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $11,250 firm fixed price purchase order to Repeat Diagnostics Inc. to provide telomere flow fluorescence in situ hybridization testing for 45 clinical samples in support of Protocol 17-H-0121. The testing is required to continue patient care, evaluate efficacy and disease progression during the course of drug therapy under the protocol. Repeat Diagnostics will perform the testing at its laboratory located in...
Repeat Diagnostics Inc. has been awarded a firm fixed price purchase order from the National Institutes of Health's National Heart, Lung and Blood Institute (NIH NHLBI) for $31,250. The contract is for specialized flow fluorescence in situ hybridization (flow-FISH) telomere length measurement services to support NHLBI research protocols and patient care through March 2025. Repeat Diagnostics will provide its Flow-FISH 2-Panel assay to measure telomere length using clinical samples, advancing the...
This federal contract award is for laboratory testing services of telomere length assays provided by Repeat Diagnostics Inc. to the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). The contract has a firm fixed price ceiling value of $4,450.00 and was awarded on December 18, 2015, with a period of performance through May 26, 2021. The contract is not associated with a set-aside designation. Repeat Diagnostics Inc. is a for-profit limited liability...
This is a $16,100.00 firm fixed price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to TRU Diagnostics Inc. The contract is to support research conducted by the Epidemiology and Community Health Branch (ECHB) and the Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LOGICO) within the NHLBI's Division of Intramural Research. The contract provides third-party laboratory services and has an ultimate completion date of September...
This is a $12,560.96 firm fixed price purchase order awarded to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, by the National Heart Lung and Blood Institute (NHLBI) on March 31, 2025. The contract supports the NHLBI lab's requirement for antibodies and cell culture media to assess antigens on the surface within human neutrophils by flow cytometry, and has a completion date of July 1, 2025. The award is not associated with a set-aside program....
This is a $49,500.00 firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. for the provision of a Xenium Prime 5K Human Pan Tissue and Pathways Assay Kit. The contract does not utilize any set-aside designations and has a period of performance through December 22, 2025. The original solicitation sought to procure specialized laboratory equipment and supplies for advanced...